Gail K Naughton

CIK 1297506 · See Remarks · last filed 2025-11-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$18.7K

Companies

5

Total Filings

59

Lifetime Open-Market Net

-$18.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TXMD Director 8,500 $2.20 $18.7K -$20.6K 9 2025-11-05
CVM Director $1.08 $0 1 2023-08-10
Histogen Inc. (HSTO) Delisted See Remarks 426,526 $0.21 $91.7K $0 2 2021-01-15
PLUS THERAPEUTICS, INC. (CYTX) Delisted Director 2,400 $2.1K 6 2017-11-29
Celera CORP (CRA) Delisted Director $0 3 2010-05-27

Recent Filings · Page 2 of 6

59 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-06-19 TXMD Grant (A) $0 EDGAR
2020-05-28 Histogen Inc. (HSTO) Delisted Other (J) +426,526 $0 EDGAR
2018-01-03 Disp (D) −1,922 $0
2017-12-05 Grant (A) +298 $0
2017-11-29 PLUS THERAPEUTICS, INC. (CYTX) Delisted Exer (X) $0 EDGAR
2017-02-01 Sell (S) −367 -$86.7K
2017-01-27 PLUS THERAPEUTICS, INC. (CYTX) Delisted Grant (A) $0 EDGAR
2016-12-15 Grant (A) +468 $0
2016-06-15 PLUS THERAPEUTICS, INC. (CYTX) Delisted Buy (P) +1,000 $2.1K EDGAR
2016-02-03 Sell (S) −584 -$109.7K
Showing 1120 of 59
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.